Research & Development
Lundbeck presents new real-world data on VYEPTI (eptinezumab) at AAN 2026
20 April 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH:HLUN-A) on Sunday presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 A...
European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe
17 April 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the European Commission has approved ENFLONSIA (clesrovimab) f...
Cumberland Pharmaceuticals secures FDA approval for expanded Caldolor indication
...
Philips secures FDA clearance for Spectral CT Verida system
...
Adimab partner GSK receives additional marketing approvals for depemokimab
16 April 2026 - Adimab LLC, a provider of therapeutic antibody discovery and engineering technologies, said on Wednesday that it congratulates biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) fo...
Gallant reports positive pilot data for feline OA stem cell therapy and FDA eligibility for expanded conditional approval pathway
16 April 2026 - Animal health biotechnology company Gallant on Wednesday reported positive results from a pilot clinical study evaluating intravenous (IV) uterine-derived mesenchymal stromal cell (UMS...